Study Identifies Gene for Ovarian Cancer

NOVEMBER 01, 2005

An excess of the Rsf-1 gene may play an important role in the development of ovarian cancer, based on an analysis of tissue from 7 ovarian cancer samples. Using a digital karyotyping technique to identify "subchromosomal alterations," the researchers observed an overproduction of the Rsf-1 gene located on chromosome 11 in 13.2% of the most aggressive forms of ovarian cancer. These results were not seen in any of the low-grade ovarian cancers.

Because this was the first study to identify this genetic alteration, the new finding may lead to the development of a drug to block the activity of Rsf-1 and therefore stop the cancerous cell growth, concluded senior researcher Tian-Li Wang, PhD, in the Proceedings of the National Academy of Sciences (September 27, 2005).




SHARE THIS SHARE THIS
0
 

The Oncology Care Pharmacist in Health-System Pharmacy 
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.